Add Yahoo as a preferred source to see more of our stories on Google. A new vaccine against salmonella and typhoid moves closer to approval, according to results of a clinical trial published by ...
PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj. ® Multi-dose is manufactured ...
Typhoid fever, a bacterial infection that causes high fever and other disabling symptoms, remains a serious global problem in the developing world: it kills almost a quarter of a million people ...
The recipients were Prof. Samuel Garba of Federal University of Technology, Minna, who developed typhoid vaccine and Dr Ololade Olatunji of University of Lagos, who developed micro-needles from fish ...
India Today on MSN
Children hit hardest as drug-resistant typhoid drives 87% of India's disease costs
Researchers estimated that 87% of the total costs were linked to infections resistant to commonly prescribed medicines, ...
Health and Me on MSN
Drug Resistance Driving Severe Typhoid Disease, Death Among Children Under-5s in India: Lancet Study
Typhoid fever caused an estimated 4.9 million cases and nearly 8,000 deaths in India in 2023. And children under-5 accounted ...
Antibiotic-resistant typhoid accounts for 87% of India’s economic burden, costing ₹123 billion in 2023, with children under 10 most affected.
Antibiotic-resistant typhoid infections accounted for at least 87 per cent of India's disease-related economic burden in 2023 ...
A study finds antibiotic-resistant typhoid caused 87% of India’s Rs 123 billion burden in 2023, with children and families ...
A new vaccine against salmonella and typhoid moves closer to approval, according to results of a clinical trial published by researchers at the University of Maryland School of Medicine Oct. 8. “These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results